Author

Daniel P. McKee

Observed names: D MCKEE, D. McKee, Daniel McKee

Institution: University of Wisconsin–Madison

Observed institutions: Albert Einstein College of Medicine, Montefiore Medical Center, University of Wisconsin–Madison, Veterans Health Administration, Hennepin County, Hennepin County Medical Center, Minneapolis VA Medical Center, University of California Davis Medical Center, St. Luke's Hospital, University of Nebraska Medical Center, University of California, Davis

ORCID: 0009-0005-2982-9183

Observed ORCID: 0009-0005-2982-9183

OpenAlex ID: A5035622716

Intestinal motility in irritable bowel syndrome: Is IBS a motility disorder?

1993 · Daniel P. McKee, Eamonn M. M. Quigley · Digestive Diseases and Sciences · 121

Intestinal motility in irritable bowel syndrome: Is IBS a motility disorder?

1993 · Daniel P. McKee, Eamonn M. M. Quigley · Digestive Diseases and Sciences · 94

Hepatitis C testing practices and prevalence in a high‐risk urban ambulatory care setting

2010 · W. N. Southern, M.‐L. Drainoni, et al. · Journal of Viral Hepatitis · 69

Response to intraluminal gas in irritable bowel syndrome

1995 · Joseph S. Galati, Daniel P. McKee, et al. · Digestive Diseases and Sciences · 61

Assessment of Alcohol and Other Drug Disorders in the Seriously Mentally Ill

1995 · K. L. Barry, M. F. Fleming, et al. · Schizophrenia Bulletin · 53

A Comprehensive Review of the Genetic and Epigenetic Contributions to the Development of Fibromyalgia

2023 · Erik A. Ovrom, Karson A. Mostert, et al. · Biomedicines · 51

High‐dose vitamin E supplementation does not diminish ribavirin‐associated haemolysis in hepatitis C treatment with combination standard α‐interferon and ribavirin

2004 · K. Saeian, J. S. Bajaj, et al. · Alimentary Pharmacology & Therapeutics · 24

Efficacy of Daily Induction Dosing vs Standard Thrice Weekly Dosing of Interferon-α2B for Initial Treatment of Chronic Hepatitis C

2002 · Hernando J. Gonzalez, Samuel B. Ho, et al. · Digestive Diseases and Sciences · 7

U.S. Multicenter Pilot Study of Daily Consensus Interferon (CIFN) Plus Ribavirin for “Difficult-to-Treat” HCV Genotype 1 Patients

2011 · Samuel B. Ho, Bashar Aqel, et al. · Digestive Diseases and Sciences · 6

High dose induction therapy with alpha interferon is effective in patients with high hepatitis C viral load

1998 · H.J. Gonzalez, S.B. Ho, et al. · Gastroenterology · 4

830 U.S. Multicenter Pilot Study of Daily Consensus Interferon (Infergen) Plus Ribavirin for “Difficult-to-Treat” HCV Genotype 1 Patients: Final Results

2009 · Samuel B. Ho, Eric Dieperink, et al. · Gastroenterology · 1

1200 High-dose vitamin E supplementation does not diminish ribavirin-associated hemolysis in chronic hepatitis C

2003 · J BAJAJ, K SAEIAN, et al. · Hepatology

Randomized, controlled trial including an initial 4-week daily "induction" period during one year of high-dose interferon alfa-2b treatment for chronic hepatitis C

2000 · Hernando J. Gonzales, Samuel B. Ho, et al. · Gastroenterology

A comparison of standard and induction interferon therapy with and without initial ribavirin in treatment na

2000 · Craig J. Peine, Jeffrey H. Albrecht, et al. · Gastroenterology

Works count: 14

Citation count: 491

H-index: 7

I10-index: 7